Page last updated: 2024-08-24

valsartan and Thromboembolism, Venous

valsartan has been researched along with Thromboembolism, Venous in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Califf, RM; Katz, M; Lopes, RD; McMurray, JJ; Sun, JL; Thomas, L	1

Trials

1 trial(s) available for valsartan and Thromboembolism, Venous

Article	Year
Venous thromboembolism and cardiovascular risk: results from the NAVIGATOR trial. The American journal of medicine, 2015, Volume: 128, Issue:3 Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Cardiovascular Diseases; Confidence Intervals; Cyclohexanes; Female; Glucose Intolerance; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Middle Aged; Nateglinide; Outcome Assessment, Health Care; Phenylalanine; Prevalence; Proportional Hazards Models; Risk Assessment; Risk Factors; Tetrazoles; Time Factors; Valine; Valsartan; Venous Thromboembolism	2015

Article

Year

Venous thromboembolism and cardiovascular risk: results from the NAVIGATOR trial.

The American journal of medicine, 2015, Volume: 128, Issue:3

Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Cardiovascular Diseases; Confidence Intervals; Cyclohexanes; Female; Glucose Intolerance; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Middle Aged; Nateglinide; Outcome Assessment, Health Care; Phenylalanine; Prevalence; Proportional Hazards Models; Risk Assessment; Risk Factors; Tetrazoles; Time Factors; Valine; Valsartan; Venous Thromboembolism

2015